Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Nectin-4-targeted peptide-drug conjugate
DRUG CLASS:
Nectin-4-targeted peptide-drug conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
BT8009 (2)
BT8009 (2)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Urothelial Cancer
No biomarker
Urothelial Cancer
BT8009
Sensitive: B - Late Trials
BT8009
Sensitive
:
B
BT8009
Sensitive: B - Late Trials
BT8009
Sensitive
:
B
NECTIN4 expression
Urothelial Cancer
NECTIN4 expression
Urothelial Cancer
BT8009
Sensitive: C3 – Early Trials
BT8009
Sensitive
:
C3
BT8009
Sensitive: C3 – Early Trials
BT8009
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.